A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043

NCT04789304 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1595043
DRUG: Placebo
DRUG: Midazolam

Sponsor

Boehringer Ingelheim